These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6104838)

  • 41. [Effects of acute and chronic treatment with an adrenergic alpha receptor agonist, LE S3341, on the rate of catecholamine turnover in various peripheral organs and brain structures in the rat].
    Rochette L; Beley A; Bralet J
    J Pharmacol; 1986; 17(4):567-77. PubMed ID: 2882066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of opioid peptides and morphine on histamine-induced catecholamine secretion from cultured, bovine adrenal chromaffin cells.
    Livett BG; Marley PD
    Br J Pharmacol; 1986 Oct; 89(2):327-34. PubMed ID: 3779215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of morphine and pentazocine on the turnover of noradrenaline and dopamine in various regions of the rat brain.
    Sugrue MF
    Br J Pharmacol; 1973 Mar; 47(3):644P. PubMed ID: 4730858
    [No Abstract]   [Full Text] [Related]  

  • 45. Catecholamine levels and tyrosine hydroxylase activities in rat brain regions after chronic treatment with, and withdrawal of, methamphetamine.
    Bardsley ME; Bachelard HS
    Biochem Pharmacol; 1981 Jun; 30(12):1543-9. PubMed ID: 6115646
    [No Abstract]   [Full Text] [Related]  

  • 46. Pituitary-adrenal activity and depletion of brain catecholamines after -methyl-p-tyrosine administration.
    Kaplanski J; Dorst W; Smelik PG
    Eur J Pharmacol; 1972 Nov; 20(2):238-40. PubMed ID: 4651212
    [No Abstract]   [Full Text] [Related]  

  • 47. Response of neurogenic amines to aggregation and strangers.
    Bliss EL; Ailion J
    J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of isolation on catecholamine concentration and turnover in discrete areas of the rat brain.
    Thoa NB; Tizabi Y; Jacobowitz DM
    Brain Res; 1977 Aug; 131(2):259-69. PubMed ID: 890457
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.
    Versteeg DH; Kovács GL; Bohus B; de Kloet ER; de Wied D
    Brain Res; 1982 Jan; 231(2):343-51. PubMed ID: 6120024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testicular cyclic nucleotide and adrenal catecholamine metabolism following chronic exposure to cadmium.
    Singhal RL
    Environ Health Perspect; 1981 Apr; 38():111-7. PubMed ID: 6113136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regression analysis of catecholamine utilization in discrete hypothalamic and forebrain regions of the male rat: effects of thyroidectomy.
    Andersson K; Eneroth P
    Acta Physiol Scand; 1985 Jan; 123(1):105-19. PubMed ID: 3881891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetic rats.
    Bitar MS; Koulu M; Rapoport SI; Linnoila M
    Biochem Pharmacol; 1987 Apr; 36(7):1011-6. PubMed ID: 2882757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and chronic morphine treatment and the hydroxylation of (1-14C)-L-tyrosine in the mouse brain.
    Marshall I; Smith CB
    Br J Pharmacol; 1974 Mar; 50(3):428-30. PubMed ID: 4152762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between analgesia and turnover of brain biogenic amines.
    Bensemana D; Gascon AL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):721-30. PubMed ID: 709413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proceedings: The effect of amantadine on the turnover of catecholamines in the rat brain.
    Brown F; Redfern PH
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():81P-82P. PubMed ID: 4156763
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of inhibition of catecholamine synthesis on central catecholamine-containing neurones in the developing albino rat.
    Loizou LA
    Br J Pharmacol; 1971 Jan; 41(1):41-8. PubMed ID: 5547761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.